Journals / Journal of Health Sciences and Medicine / 2022 / Cilt: 5 - Sayı: 2

Evaluating the clinical, radiological, microbiological, biochemical parameters and the treatment response in COVID-19 pneumonia

Pages
544–551
Publication Date
2022-03-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The involvement severity scores were negatively correlated with the lymphocyte count, lymphocyte percentage, and albumin levels ​​(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The coronavirus disease (COVID-19) has led to over 200,000,000 confirmed cases and over 4,250,000 confirmed deaths worldwide.
📊
Key Findings & Data:The present study aimed to explore the links between epidemiological, clinical, biochemical, microbiological, and radiological data and treatment responses of inpatients with COVID-19 pneumonia.
💡
Conclusion & Impact:The involvement severity scores were negatively correlated with the lymphocyte count, lymphocyte percentage, and albumin levels ​​(p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · Pneumonia · clinical parameters

Abstract

Aim: The coronavirus disease (COVID-19) has led to over 200,000,000 confirmed cases and over 4,250,000 confirmed deaths worldwide. The present study aimed to explore the links between epidemiological, clinical, biochemical, microbiological, and radiological data and treatment responses of inpatients with COVID-19 pneumonia. Material and Method: The study included 131 patients hospitalized for COVID-19 pneumonia. Laboratory values ​​such as complete blood count, coagulation profile, AST, LDH, sedimentation, CRP, BUN, creatinine, and D-dimer of the patients were analyzed. The diagnosis of COVID-19 was established by RT-PCR testing of respiratory tract samples. Thoracic CT images were used to determine the severity of involvement in patients. Statistical analyses were performed to establish the differences between the groups and the relationships between the variables. Results: The most common comorbidities of the patients were hypertension (35.1%) and diabetes mellitus (24.5%). The patients with fever, cough, and dyspnea and who were PCR positive had the highest radiological involvement severity score. The involvement severity scores were negatively correlated with the lymphocyte count, lymphocyte percentage, and albumin levels ​​(p

🔖

Cite This Article

MUTLU, P., MİRİCİ, A., GÖNLÜGÜR, U., OZTOPRAK, B., ÖZER, Ş., REŞORLU, M., AKÇALI, A., ÇAKIR, D. Ü., DOĞAN, C. R. (2022). Evaluating the clinical, radiological, microbiological, biochemical parameters and the treatment response in COVID-19 pneumonia. Journal of Health Sciences and Medicine, Cilt: 5 - Sayı: 2, 544–551. https://ajindex.com/articles/776606

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Sun P, Lu X, Xu C, et al. Understanding of COVID-19 based on current evidence. J Med Virol 2020; 92: 548-51.
  2. Zhu N, Zhang D, Wang W, et al. A Novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727-33. Health Mo. Ulusal Pandemi Hazırlık Planı Secondary Ulusal Pandemi Hazırlık Planı 2019. https: //hsgm.saglik.gov.tr/tr/bulasicihastaliklar-haberler/ulusal-pandemi-hazirlik-plani.html Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (London, England) 2020; 395: 514-23.
  3. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-73.
  4. Lillie PJ, Samson A, Li A, et al. Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission. J Infect 2020; 80: 578-606.
  5. Spina S, Marrazzo F, Migliari M, et al. The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy. Lancet (London, England) 2020; 395: e49-e50. WHO. Coronavirus disease (COVID-19) pandemic. Secondary coronavirus disease (COVID-19) pandemic 2021. https: //www.who.int/emergencies/diseases/novel-coronavirus-2019.
  6. Chan KS, Lai ST, Chu CM, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J=Xianggang yi xue za zhi 2003; 9: 399-406.
  7. Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis 2019; 68: e1-e47. Hoehl S, Rabenau H, Berger A, et al. Evidence of SARS-CoV-2 Infection in returning travelers from Wuhan, China. N Engl J Med 2020; 382: 1278-80. Bakanlığı TCS. COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi (Bilim Kurulu Çalışması). Secondary COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi (Bilim Kurulu Çalışması) 2020. https: //covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf. Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Global Health 2020; 8: e641-e42. Liu J, Cao R, Xu M, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery 2020; 6: 16. Schrezenmeier E, Dorner T. Mechanisms of action o